We established a rapid detection method based on recombinant enzyme polymerase amplification (RPA) for the simultaneous detection and identification of Actinobacillus pleuropneumoniae (A. pleuropneumoniae) and Streptococcus suis (S. suis). A pair of primers and corresponding probes were designed for the glutamate dehydrogenase (gdh) gene of S. suis and the ApxIV gene of A. pleuropneumoniae to establish a dual RPA-LFD detection method for the rapid identification of S. suis and A. pleuropneumoniae. The specificity test showed that the amplification results for Pasteurella, E. coli, Salmonella, S. aureus, H. parasuis and A. hydrophila were all negative, indicating the good specificity of the method. The sensitivity test showed that the lowest nucleic acid concentration that was detectable with this method was 10− 5 ng/µL, which was significantly higher than that of PCR and RPA-Basic. S. suis and A. pleuropneumoniae reference strains, clinical isolates and 45 clinical lung tissue samples were detected with this method. The results showed that this method detected all reference strains and clinical isolates, which was consistent with the PCR detection results. Among the 45 clinical samples, 19 cases of S. suis and 1 case of A. pleuropneumoniae were detected, and there were no mixed infections. The detection rate was higher than that of bacterial isolation and the conventional PCR method, indicating that this method is very practical and suitable for the rapid clinical detection of S. suis and A. pleuropneumoniae. Compared with the traditional method, the dual RPA-LFD method has several advantages including a high specificity, high sensitivity, fast speed (detection time of 20 min) and minimal requirement for instruments and equipment; in addition, the method can realize the synchronous and rapid detection of S. suis and A. pleuropneumoniae and is helpful for the preliminary screening of clinical diseases.